Previous studies have shown that cholinergic stimulation results in a prostanoid-dependent cerebral vasoconstriction in piglets. The present study specifically investigated the contribution of thromboxane A2 (TXA2)/prostaglandin endoperoxide and prostaglandin F2a (PGF2) to the cerebral vascular response to exogenous acetylcholine (ACh). Effects of TXA2/prostaglandin endoperoxide-receptor antagonist SQ29548 on responsiveness of pial arterioles to ACh (10-7 and 10`M), PGF2U (10-7_10-5 M), TXA2 mimetic 9,11-methanoepoxy prostaglandin H2 (U46619, 5 and 10 ng/ml), and norepinephrine (14E6-104 M) were studied by use of a closed cranial window in 37 anesthetized mechanically ventilated newborn piglets. Pial arteriolar diameter was measured by intravital microscopy. Topical application of exogenous PGF2, and U46619 resulted in dose-dependent cerebral vasoconstriction, and the dose-response curve for each agonist was shifted to the right by the increasing concentrations of SQ29548 (10-6_10-8 M). Topical application of high concentration of ACh (10-4 M) caused a transient 34±4% decrease in pial arteriolar diameter from 98±6 to 65±5 ,um (p<0.05). This constriction was attenuated (16±3%) in the presence of 10~8 M SQ29548 and abolished with 10-6 or 10-4 M SQ29548. SQ29548 (10-6 M) was without effect on the vasoconstrictor response to exogenous norepinephrine. Low concentration of ACh (10`M) had no consistent effect on pial arterioles in the absence or presence of TXAJprostaglandin endoperoxide-receptor blockade. The data suggest that vascular prostaglandin/endoperoxide receptors mediate cerebral vasoconstriction upon muscarinic-receptor stimulation. (Circulation Research 1990;66:824-831) 
T he dilator response to acetylcholine (ACh) is mediated by release of a nonprostaglandin endothelium-derived relaxing factor in many vascular preparations,1-5 including the cerebral circulation of dogs, cats, rabbits, and mice.6-12 On the other hand, ACh-induced vasoconstriction has been shown in dog and pig cerebral arteries13-17 that could be attenuated by removal of the endothelium. 13 Studies of the newborn piglet pial circulation from our laboratories16 have shown that the primary cerebrovascular response to ACh in this species is an atropine-sensitive constriction, especially at high concentrations. We have also demonstrated that application of ACh to the cortical surface is associated with a profound increase in the concentration of both vasoconstrictor and vasodilator prostanoids in the cerebrospinal fluid (CSF) bathing the pial arterioles.18 In addition, the pial arteriolar constriction could be blocked with indomethacin,16 suggesting that prostanoids mediated the vascular response to muscarinic activation. Thus, one means by which the cerebral constrictor response occurs may be via production of potent constrictor prostanoids that may conceal any prostaglandin or nonprostaglandin vasodilator mechanism of ACh.
To understand further the mechanism of cholinergic function and the role of vasoconstrictor eicosanoids in the newborn piglet cerebral circulation, the present study investigates the relative efficacy of thromboxane A2/prostaglandin endoperoxide (TP)receptor antagonist SQ29548 on cerebrovascular responsiveness to thromboxane A2 (TXA2) mimetic U46619, prostaglandin F2a (PGF2a), and ACh, testing the hypothesis that TXA2 mediates cholinergic vasoconstriction. In addition, we examined the possibility that cholinergic vasodilation in piglet cerebral arteries is present but is obscured by release of potent constrictor prostanoids.
Materials and Methods Animal Preparation
Experiments were carried out on 37 newborn piglets 2-7 days of age. Piglets were anesthetized with sodium pentobarbital (30 mg/kg i.p., 5 mg/kg/hr maintenance). After tracheostomy, polyethylene catheters were placed into a femoral artery and vein to monitor arterial blood pressure and for fluid administration. A continuous intravenous drip (12 ml/hr) of 5% glucose was started and continued throughout the experiment. Skeletal muscle paralysis was induced with 0.5 mg pancuronium bromide given intravenously. The piglets were mechanically ventilated, and end-expiratory CO2 was continuously monitored with an infrared CO2 analyzer (Beckman Instruments, Fullerton, California). End-expired Pco2 was maintained between 30 and 35 mm Hg, and Pao2 was maintained between 80 and 100 mm Hg. Animals were wrapped in a warming blanket, and core body temperature was continuously monitored and maintained at 380 C. Arterial blood pressure was measured with a Statham P23Db pressure transducer (Gould Instruments, Cleveland, Ohio) connected to the femoral arterial catheter. Arterial blood samples were collected and analyzed for pH, Pco2, and Po2 at appropriate times during the experimental protocols. Blood gas tensions and pH were measured with conventional electrodes (Radiometer America, Westlake, Ohio), and hemoglobin concentration and saturation were measured with a co-oximeter (Instrumentation Laboratories, Lexington, Massachusetts). Hematocrit was measured by micromethod.
The piglets were equipped with a closed cranial window placed over the left parietal lobe as previously described for newborn piglets. 16, 19 The space under the window was filled with artificial CSF of the following composition (mM): KCI 2.9, MgCl2 1.4, CaCI 1.2, NaCI 132, NaHCO3 24.6, urea 6.7, and glucose 3.7. The CSF was warmed to 390 C and equilibrated with 6.6% C02, 6.0% 02, with the balance N2. We have previously demonstrated that injecting artificial CSF of this composition under the window has no effect on pial vascular caliber. 19, 20 Pial arterioles ranging in diameter from 58 to 143 gum were visualized with a trinocular stereomicro- 
Experimental Protocols
Effect of SQ29548 on pial arteriolar response to acetylcholine. In 16 piglets, the response of pial arterioles to ACh was determined in the absence and presence of TP-receptor antagonist SQ29548. Baseline measurements of pial arteriolar diameter were made after flushing the cortical surface with CSF containing no drug. Then ACh in doses of 10`and 10`4 M in CSF was flushed, sequentially, under the window onto the cortical surface. Each ACh concentration was left on the surface for 4-5 minutes and was then replaced with the next concentration. We elected to use these two ACh concentrations because previous studies16 have indicated that the low concentration may optimize vasodilator mechanisms and that vasoconstrictor mechanisms were most prominent at the higher concentration. After determination of the pial arteriolar response to each ACh concentration during control conditions, ACh was washed off of the cortical surface, and a recovery period of at least 45 minutes was allowed. SQ29548 in CSF was flushed onto the cortical surface for a period of 20 minutes, and the response to ACh was determined again in the presence of SQ29548. The concentrations of SQ29548 used were 108 M (n=5), 10-6 M (n=5), and 10-4 M (n=6).
Effect of SQ29548 on pial arteriolar sensitivity to U46619, PGF2a, and norepinephnine. To investigate the specificity of SQ29548 for vascular TP receptors, we examined the pial arteriolar response to TPreceptor agonist U46619, vasoconstrictor prostanoid PGF2a, and neurotransmitter norepinephrine. To prevent interference from endogenous production of vasoactive prostanoids, these experiments were performed after cyclooxygenase inhibition with indomethacin (5 mg/kg i.v.).21 In eight piglets, baseline measurements of pial diameter were made after flushing the cortical surface with control CSF; after which, the response to U46619 (3 and 10 ng/ml) was determined in cumulative manner. After washout of U46619 and a recovery period of 45 minutes, the pial vascular response to the TP-receptor agonist was reexamined in the presence of SQ29548 in concentrations of 10`8 M (n=4) or 10-6 M (n=4).
In another group of eight piglets, the pial arteriolar response to PGF2, (10-7-10-5 M) was determined during control and in the presence of 10-8 (n=4) or 10`6 M (n=4) SQ29548 in a manner analogous to that described for U46619 above.
The effect of 10-6 M SQ29548 on the a-adrenergic vasoconstriction to exogenous norepinephrine (10-6_ 10-4 M in CSF) was determined in five additional piglets.
Statistical Analysis
All values are presented as mean±SEM. Comparisons among treatments were made with repeatedmeasures analysis of variance followed by Student-Newman-Keuls test when appropriate. Analysis of pial diameters was made after square root transformation and percent changes were analyzed after arcsine transformation. Differences were considered significant when p< 0.05.
Results

Effect of SQ29548 on the Pial Arteriolar Response to Acetylcholine
Pial arteriolar diameter and mean arterial blood pressure during application of ACh during control and in the presence of three concentrations of SQ29548 are presented in Table 1 . Arterial pH, Pco2, and Po2 during control measurements of pial arteriolar diameter and in the presence of SQ29548 are also presented in Table 1 . Application of 10 'M ACh to the cortical surface resulted in no consistent alteration of arteriolar diameter; however, application of 10-4 M ACh decreased pial diameter similarly in all three groups of animals by an average of 34+±4% ( Figure 1 ). As we have reported previously,16 the decrease in diameter observed at high concen-trations of ACh was transient where the peak effect was noted within 1 minute; by 4 Table 1 . *Significantly different from control at pcO.05. and iO-`M) did not significantly influence the effect of the low dose of ACh (10-`M); however, in the presence of 10-6 M SQ29548, there was a 9±5% dilation to low-dose ACh (Figure 1 ).
Effect of SQ29548 on Pial Vascular Sensitivity to U46619, PGF2a, and Norepinephrine Pial arteriolar diameter and mean arterial blood pressure after topical application of U46619 and PGF2a at control and in the presence of 10-8 and 10-6 M SQ29548 are presented in Tables 2 and 3 . Arterial blood gases and pH during control and in the presence of SQ29548 are also presented in Tables 2 and  3 . Both U46619 (3 and 10 ng/ml) and PGF2a ( The effect of 10-6 M SQ29548 on the pial arteriolar response to norepinephrine is shown in Figure  4 . Exogenous norepinephrine applied to the pial surface caused a dose-dependent decrease in pial arteriolar diameter from control of 99±4 gm to 81±8 gm at the maximum norepinephrine concentration of 10-4 M. The contractile response to norepinephrine was unchanged in the presence of SQ29548 (10-6 M) where diameter decreased from 97±6 to 81±5 ,um. Arterial blood gases and blood pressure were not altered by norepinephrine nor were they affected by SQ29548. Base 7 6 5 PGF2a (-log M) cortical synthesis of prostanoids, and is blocked by pretreatment with indomethacin. 16, 18 This response has been attributed to M1 muscarinic receptors since the response was blocked by atropine16 as well as by M1-receptor antagonist pirenzipine and was mimicked by M1-agonist McN-A-343. 17 The present study investigated the role of the potent constrictor TXA2 in the cholinergic mechanism of newborn pig cerebral arteries by examining the effect of the TPreceptor antagonist SQ29548 on the response to topically applied ACh. Since the subarachnoid CSF concentration of PGF2a as well as thromboxane B2 (the hydrolysis product of TXA2) was shown to increase after ACh,18 we also examined the efficacy of SQ29548 on PGF2a.
The new finding of the present study is that SQ29548 inhibited the constrictor response to high concentrations of ACh in cerebral arteries of newborn piglets, suggesting that vascular TP receptors mediate the constrictor response. SQ29548 also inhibited the response to TXA2 mimetic U46619 and PGF2a to an equivalent extent, suggesting that these agonists exert their effects through a common TP receptor. The low affinity of PGF2a for these receptors, however, deems its role in the cholinergic constrictor response unlikely. We conclude that the cholinergic constriction in piglet pial arterioles is mediated by TXA2 or an endoperoxide intermediate of the cyclooxygenase pathway, such as prostaglandin H2, acting on vascular TP receptors. Furthermore, blockade of these receptors does not reveal a vasodilator response to either low or high concentrations of ACh, indicating that a prostanoid-dependent dila-0 vU Wagerle and Busija Cerebrovascular TXA2 Receptors and Cholinergic Function 829 tor response to muscarinic activation is not operative in the piglet pial circulation.
TXA2 is a potent constrictor of cerebral arterioles, 22 and recent studies indicate that TXA2 can be generated in brain or brain vessels in sufficient amounts to cause vasoconstriction. 23 Previous studies have suggested that SQ29548 may be used to investigate the role of TXA2 in physiological and pathological states.2425 The present study suggests that SQ29548 is also a potent antagonist for TXA2 receptors in the piglet cerebral circulation since it inhibited the constrictor effect of TXA2 mimetic U46619 at a low concentration (10-8 M) . Additionally, a 100-fold increase in SQ29548 concentration had no effect on the constriction to norepinephrine but blocked the constriction to U46619, providing further support for the specificity of the antagonist. Similar specificity for SQ29548 was demonstrated in cerebral arteries of adult mice. 23 In the present study, however, SQ29548 exhibited an equipotent antagonism of PGF2a. Thus, in the piglet cerebral circulation, the vascular response to prostaglandin H2 metabolites, PGF21 and TXA2, appears to be mediated by indistinguishable vascular TP receptors. A similar conclusion was reached in canine cerebral arteries in which TXA2 analogue ON03708 caused equipotent inhibition of the constrictor responses to PGF2a, prostaglandin E2, prostaglandin H2, and a TXA2 analogue.26 Also in cat coronary arteries, SQ29548 blocked the constrictor effect of both U46619 and PGF2a. 24 The distinction between TXA2-and PGF2areceptor mechanisms, however, appears to depend on the species and/or tissue type under investigation. In guinea pig tracheal and rat aortic smooth muscle, for example, SQ29548 is a relatively selective TXA2 antagonist because it antagonized the response to TXA2 mimetics but did not affect the contractile response to PGF2a except at high concentrations of SQ29548 in which the response was only partially antagonized.25 Similarly, in canine pulmonary artery, the constriction to PGF2a but not U46619 was blocked by intracellular calcium antagonist TMB-8,27 suggesting different contraction coupling mechanisms for the two agonists.
When SQ29548 was administered alone in the present study, there was a 6% increase in diameter in the ACh group, suggesting that vascular TP receptors exert some constrictor tone during baseline conditions, perhaps due to endogenous production of endoperoxide metabolites. The fact that SQ29548 alone had no dilator effect in the group of animals pretreated with indomethacin (i.e., PGF2a and U46619 groups) also supports this possibility.
The present study focused on only two concentrations of ACh, low (10-7 M) and high (10`4 M) .
Clearly the latter is much greater than that necessary to activate muscarinic receptors, and therefore, its physiological relevance should be interpreted with caution. However, cerebral vasoconstriction and synthesis of cortical prostanoids to ACh was noted at lower concentrations as well.13'16'18 Furthermore, estimates of adrenergic neurotransmitter concentration at or near the synaptic cleft suggest that peak concentrations as high as 10`M may be achieved.28
Nevertheless, the high dose of ACh used in the present study was selected to isolate the mechanism of the contractile response to ACh, which occurs most consistently at concentrations greater than 10-5 M,16 and to evaluate its impact on the vasodilator response to low concentrations of ACh.
In most vascular preparations, cholinergic dilation is mediated by an endothelium-derived relaxing factor that is not a product of the cyclooxygenase pathway.1,4,5 The cholinergic constriction in piglet cerebral arterioles is somewhat atypical; however, cholinergic constriction has also been reported in the dog saphenous vein,29 dog and rabbit pulmonary arteries,30,31 and cerebral arteries of premature baboons32 and dogs. 13, 15 We hypothesized, however, that the pig may possess a dilator response to ACh that is overridden by the local synthesis of constrictor prostanoids. We have shown previously that inhibition of prostaglandin synthesis did not reveal a dilator response to ACh in the newborn piglet pial circulation, suggesting that these vessels either do not produce classical endothelium-derived relaxing factor or are unresponsive to it. 16 The fact that those arteries responded vigorously to another endothelium-dependent dilator, bradykinin, indicated that the endothelium was intact. The vessels also dilated to sodium nitroprusside (authors' unpublished observations), indicating that cyclic GMP-dependent vasodilator mechanisms, through which endotheliumderived relaxing factor induces vascular smooth muscle relaxation,5 are present. The present study extends these findings because specific inhibition of TP receptors (that would not interfere with phospholipid metabolic pathways) also failed to unmask a dilator response to ACh. There was a significant 9% dilation to the low concentration of ACh (10`M) after administration of 10-6 M SQ29548 (Figure 1) ; however, dilation was not noted at 10-4 M ACh, and there was no dilator response at either ACh concentration after 10-4 M SQ29548. Thus, the inconsistency of the vasodilation to ACh after TP-receptor blockade supports the contention that the newborn piglet pial circulation does not produce endotheliumderived relaxing factor in response to ACh.
Interestingly, high concentration of PGF2a (10-5 M) caused a 13% increase in diameter (Figure 3) after TP-receptor blockade. The mechanism for this dilator response is not clear; however, it is possible that PGF2a may have some affinity for other prostaglandin receptors such as prostaglandin E2.26 Prostaglandin E2 causes dilation in pig pial arteries and is structurally very similar to PGF2a. Activation of muscarinic receptors results in hydrolysis of membrane phosphoinositides and generates both inositol triphosphate, which releases calcium from intracellular stores, and diacylglycerol in various tissues,3334 including vascular smooth muscle. 35, 36 Arachidonic acid and prostanoids may be derived either from further degradation of diacylglycerol or via activation of membrane phospholipases by increased intracellular calcium. Direct activation of muscarinic receptors on smooth muscle cells results in increased tension; however, in most vessels with intact endothelium, muscarinic activation results in release of an endothelium-derived relaxing factor that diffuses to local vascular smooth muscle, causing dilation.1,4,5 In some vessels, endothelium-dependent constriction has been demonstrated.1315 In cerebral arteries, dilator6-8'10-12 and constrictor responses,'3-17 as well as no response,37 to ACh have been reported, and the constrictor response may be blocked by inhibition of prostaglandin synthesis. 16 In the newborn piglet, prostaglandins are important in cerebrovascular regulatory processes, in which they contribute to the responses to asphyxia, hemorrhagic hypotension, respiratory acidosis, bicucculine seizures, and cholinergic stimulation. '6,19213839 The present study provides evidence that vascular TP receptors mediate the cholinergic vasoconstriction, suggesting that local release of TXA2 or prostaglandin endoperoxide plays a dominant role in the constrictor response to high concentrations of ACh.
